SERB Pharmaceuticals

Our Rare Emergency team is thrilled to be back at EAPCCT, attending their 46th annual congress. Toxicology experts play a vital role in patient care and preparedness every day - we're looking forward to this invaluable opportunity to connect and exchange insights.     Visit us at booth 1      Find out more here: link to EAPCCT web      May 26-29, 2026 | Vilnius, Lithuania       The European Association of Poison Centres and Clinical Toxicologists (EAPCCT)  #Poison #Toxicology #EAPCCT2026 #SERB 

This week we are pleased to be attending the 7th International Conference of CBRNe Research & Innovation, in Arcachon, France. Covering topics including detection and decontamination, this conference provides a vital platform to share knowledge, strengthen collaboration and discuss the latest innovations in CBRN #preparedness, #medicalcountermeasures and #crisismanagement.   Find out more about the conference here https://lnkd.in/dBeyqAh #CBRN #CBRNe

𝗡𝗲𝘄𝘀 𝗳𝗼𝗿 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗮: We’re pleased to announce an agreement to acquire the exclusive rights to a commercial-stage immunosuppressive medicine in kidney transplantation in Europe and the MENA region. This is a strong fit for SERB: bringing a new medicine for patients facing a rare and urgent condition into our portfolio and building on our established presence in Europe and MENA, as well as our experience working in complex, specialist settings. We’re eager to expand the reach and impact of this medicine for the patients who need it. For more information, please visit: https://serb.com/ #RareAndUrgent #RareDisease #Europe #MENA

Visit us at Booth 402 to explore the latest innovations in Rare Emergency Medicine and Rare Oncology, discuss advancements in patient care, and meet our team. Looking for a more in-depth conversation? Join us at our Hospitality Suite 6-9 pm CT in the Combs Chandler Room for insightful discussions in a relaxed setting. Let’s shape the future of healthcare together—see you there!

Heading to the 2026 HCP Spring Conference? We’d love to connect! Join us at booth 402 to explore how SERB is helping drive innovations in Emergency Medicine and Rare Disease and meet our team. Let’s shape the future of healthcare together—see you there!

SERB | In our own words - Natalie Notoris Our Regional Business Manager of Rare Oncology, Natalie Notoris, shares what it's like to work in the field in the US, how managers have supported her in her role, and why a passion for education matters. Watch the video on our YouTube page here https://lnkd.in/ecJg6UTq #LifeatSERB #SERB

We’re thrilled to be exhibiting at the Society for Academic Emergency Medicine Annual Meeting again this year in Atlanta, where leading academics and professionals in #EmergencyMedicine are coming together to advance research, education, and innovative approaches to patient care. As part of SAEM 2026, we’re also excited to partner on the MedWAR Challenge on May 18 in Piedmont Park—a fast-paced, team-based competition tackling simulated medical emergencies. Visit SERB Pharmaceuticals at booth #202. We look forward to meeting you there! Find out more here: https://lnkd.in/g7fmxp4q May 18-21, 2026 | Atlanta, Georgia #SAEM2026 #SERB

We’re hiring! We have three new commercial roles available in the US. If you want to be part of our growing US Oncology team, we’d love to hear from you. ·        Rare Oncology – Inside Sales Representative (Philadelphia office-based)  ·        Pediatric Rare Oncology – Key Account Manager (US field-based, Texas)  ·        Rare Oncology – Key Account Manager (US field-based, California)    Learn more about the roles and apply here: https://lnkd.in/eR4arTpd     Now is the time to join SERB Pharmaceuticals’ Rare Oncology sales team. Backed by deep clinical expertise, bold commercial ambition and a strong duty to patients, we’re fast-expanding our Rare Oncology portfolio to become true leaders in the field. #Hiring #Oncology #RareDisease #PharmaJobs #Sales #Commercial #KeyAccountManager #California #Philadelphia #Texas  

We are excited to announce that our CEO Vanessa Wolfeler, will be attending Fierce Biotech Week and presenting on ‘Commercializing Therapies for Rare and Critical Care Populations’ • Date: Wed, May 13  • Time: 03:25 PM – 03:50 PM  • Location: Picasso 1 & 2 In this presentation, Vanessa will draw on SERB's extensive experience delivering medicines for rare and urgent conditions, to share real-world case studies of commercialization in complex markets. You can find more details about this session here:  https://lnkd.in/eKC_aN4u Fierce Biotech Week is a premier gathering of biotech and pharma innovators in Boston, MA, featuring panels on drug development, clinical operations, and commercialization. More about Fierce Biotech Week: https://lnkd.in/guwi2eXZ #RareDiseases #CriticalCare  #FBW2026 #fiercebiotechweek #fbw2026  Fierce Life Sciences Events

For healthcare professionals only: That’s a wrap on SIOP Europe 2026 in Glasgow. Great to be there for tumour-group sessions, new insights, and conversations with HCPs across paediatric oncology. Thanks SIOP Europe and Childhood Cancer International - Europe - let’s keep the conversation going!